Medimaging Integrated Solution Inc.(TW:6796)
NT$49.20-1.60 (-3.15%)
TW:6796
Medimaging Integrated Solution Inc. financials statements
NT$49.20
At close:-1.60 (-3.15%)
Medimaging Integrated Solution Inc. (6796) Ratios
Medimaging Integrated Solution Inc. Ratios
TW:6796's free cash flow for Q2 2026 was NT$-38.71M. For the 2026 fiscal year, TW:6796's free cash flow was decreased by NT$-5.08M and operating cash flow was NT$-33.63M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.26 | 3.69 | 5.66 | 5.13 | 3.37 |
| Quick Ratio | 1.72 | 2.75 | 4.76 | 3.89 | 2.53 |
| Cash Ratio | 1.18 | 1.74 | 2.91 | 2.25 | 1.41 |
| Solvency Ratio | 0.08 | 0.10 | 0.19 | 0.52 | 0.43 |
| Operating Cash Flow Ratio | -0.04 | -0.23 | 1.03 | 0.92 | 0.29 |
| Short-Term Operating Cash Flow Coverage | -0.05 | -1.15 | 9.06 | 6.15 | 0.71 |
| Net Current Asset Value | NT$ 201.62M | NT$ 181.85M | NT$ 376.40M | NT$ 432.88M | NT$ 305.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.43 | 0.33 | 0.30 | 0.10 | 0.19 |
| Debt-to-Equity Ratio | 0.90 | 0.60 | 0.51 | 0.14 | 0.28 |
| Debt-to-Capital Ratio | 0.47 | 0.37 | 0.34 | 0.12 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.32 | 0.30 | 0.07 | 0.10 |
| Financial Leverage Ratio | 2.11 | 1.83 | 1.69 | 1.30 | 1.47 |
| Debt Service Coverage Ratio | 0.22 | 0.84 | 4.48 | 5.14 | 1.54 |
| Interest Coverage Ratio | 1.57 | -0.28 | 23.89 | 42.15 | 83.84 |
| Debt to Market Cap | 0.17 | 0.13 | 0.10 | 0.03 | 0.06 |
| Interest Debt Per Share | 17.93 | 11.78 | 11.04 | 2.54 | 4.27 |
| Net Debt to EBITDA | 1.81 | 1.34 | -0.58 | -1.58 | -0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 41.81% | 43.48% | 57.30% | 50.67% | 52.63% |
| EBIT Margin | 2.71% | -0.70% | 18.03% | 17.69% | 16.86% |
| EBITDA Margin | 11.26% | 9.45% | 22.22% | 23.70% | 23.65% |
| Operating Profit Margin | 2.71% | -0.45% | 17.11% | 11.89% | 17.82% |
| Pretax Profit Margin | 2.21% | 2.27% | 17.31% | 17.41% | 16.65% |
| Net Profit Margin | 1.17% | 1.04% | 13.79% | 13.95% | 13.68% |
| Continuous Operations Profit Margin | 1.17% | 1.04% | 13.79% | 13.95% | 13.68% |
| Net Income Per EBT | 52.74% | 45.92% | 79.64% | 80.10% | 82.17% |
| EBT Per EBIT | 81.75% | -505.21% | 101.16% | 146.44% | 93.43% |
| Return on Assets (ROA) | 0.49% | 0.41% | 5.52% | 8.32% | 9.29% |
| Return on Equity (ROE) | 1.04% | 0.76% | 9.34% | 10.80% | 13.68% |
| Return on Capital Employed (ROCE) | 1.60% | -0.21% | 7.81% | 8.30% | 15.55% |
| Return on Invested Capital (ROIC) | 0.66% | -0.09% | 6.10% | 6.46% | 11.43% |
| Return on Tangible Assets | 0.50% | 0.42% | 5.59% | 8.44% | 9.46% |
| Earnings Yield | 0.21% | 0.19% | 2.03% | 3.09% | 3.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.17 | 2.78 | 5.50 | 4.15 | 3.29 |
| Payables Turnover | 10.88 | 10.25 | 22.36 | 8.74 | 12.29 |
| Inventory Turnover | 1.56 | 1.50 | 1.55 | 1.63 | 1.73 |
| Fixed Asset Turnover | 1.39 | 1.09 | 1.43 | 2.64 | 3.08 |
| Asset Turnover | 0.42 | 0.40 | 0.40 | 0.60 | 0.68 |
| Working Capital Turnover Ratio | 1.15 | 0.80 | 0.85 | 1.14 | 1.44 |
| Cash Conversion Cycle | 315.09 | 339.11 | 285.99 | 269.70 | 292.58 |
| Days of Sales Outstanding | 115.23 | 131.30 | 66.38 | 88.00 | 110.90 |
| Days of Inventory Outstanding | 233.40 | 243.41 | 235.93 | 223.46 | 211.38 |
| Days of Payables Outstanding | 33.54 | 35.60 | 16.33 | 41.75 | 29.70 |
| Operating Cycle | 348.63 | 374.71 | 302.32 | 311.45 | 322.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.42 | -1.31 | 4.55 | 3.21 | 1.44 |
| Free Cash Flow Per Share | -1.39 | -4.59 | -0.83 | 1.77 | 0.47 |
| Dividend Paid and CapEx Coverage Ratio | -0.30 | -0.27 | 0.65 | 1.09 | 0.69 |
| Capital Expenditure Coverage Ratio | -0.44 | -0.40 | 0.84 | 2.22 | 1.49 |
| Operating Cash Flow Coverage Ratio | -0.02 | -0.11 | 0.42 | 1.29 | 0.34 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.09 | 0.31 | 0.22 | 0.09 |
| Free Cash Flow Yield | -1.48% | -5.81% | -0.85% | 2.74% | 0.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 471.00 | 543.13 | 49.32 | 32.30 | 28.29 |
| Price-to-Sales (P/S) Ratio | 5.45 | 5.62 | 6.80 | 4.51 | 3.86 |
| Price-to-Book (P/B) Ratio | 4.83 | 4.08 | 4.61 | 3.50 | 3.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -67.63 | -17.22 | -118.15 | 36.52 | 123.97 |
| Price-to-Operating Cash Flow Ratio | -222.92 | -60.11 | 21.69 | 20.09 | 40.81 |
| Price-to-Earnings Growth (PEG) Ratio | 12.56 | -5.86 | 0.00 | -9.20 | 1.41 |
| Enterprise Value Multiple | 50.16 | 60.85 | 30.02 | 17.47 | 15.55 |
| Enterprise Value | 3.74B | 3.10B | 3.58B | 2.08B | 1.79B |
| EV to EBITDA | 50.16 | 60.85 | 30.02 | 17.47 | 15.55 |
| EV to Sales | 5.65 | 5.75 | 6.67 | 4.14 | 3.68 |
| EV to Free Cash Flow | -70.16 | -17.61 | -115.91 | 33.50 | 118.10 |
| EV to Operating Cash Flow | -231.28 | -61.46 | 21.27 | 18.43 | 38.88 |
| Tangible Book Value Per Share | 18.77 | 18.68 | 20.95 | 18.13 | 14.79 |
| Shareholders’ Equity Per Share | 19.49 | 19.36 | 21.40 | 18.47 | 15.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.47 | 0.54 | 0.20 | 0.20 | 0.18 |
| Revenue Per Share | 17.30 | 14.05 | 14.51 | 14.31 | 15.19 |
| Net Income Per Share | 0.20 | 0.15 | 2.00 | 2.00 | 2.08 |
| Tax Burden | 0.53 | 0.46 | 0.80 | 0.80 | 0.82 |
| Interest Burden | 0.82 | -3.23 | 0.96 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.22 | 0.26 | 0.24 | 0.25 | 0.22 |
| SG&A to Revenue | 0.17 | 0.18 | 0.16 | 0.14 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | -2.09 | -4.13 | 1.81 | 1.29 | 0.57 |
Currency in TWD
